Characterization of the molecular mechanisms of quinolone resistance in Yersinia enterocolitica O:3 clinical isolates

Journal of Antimicrobial Chemotherapy

Volumn 53, Issue 6, 2004, Pages 1068-1071

  Capilla, S ^a   Ruiz, J ^b   Goni P ^a   Rubio, M C ^a   Jimenez de Anta M T ^c   Gomez Lus R ^a   Vila, J ^c  

^a UNIVERSITY OF ZARAGOZA   (Spain)

^b UASP ^*  (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Phe Arg naphthylamide; Quinolones; Y. enterocolitica

Indexed keywords

2 NAPHTHYLAMINE; CIPROFLOXACIN; DNA TOPOISOMERASE (ATP HYDROLYSING) A; NALIDIXIC ACID; PROTEIN PARC; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BACTERIUM MUTANT; CONTROLLED STUDY; DILUTION; GENE MUTATION; GENE OVEREXPRESSION; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; REGULATORY MECHANISM; STRAIN DIFFERENCE; YERSINIA ENTEROCOLITICA;

ANTI-INFECTIVE AGENTS; CIPROFLOXACIN; DIPEPTIDES; DNA GYRASE; DNA TOPOISOMERASE IV; DRUG RESISTANCE, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; MUTATION; NALIDIXIC ACID; QUINOLONES; SPAIN; YERSINIA ENTEROCOLITICA; YERSINIA INFECTIONS;

EID: 3042685848     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkh225     Document Type: Article

References (10)

1. Bottone, E. J. (1999). Yersinia enterocolitica: overview and epidemiologic correlates. Microbes and Infection 1, 323-33.
2. Castillo, F. J., Larraz, V., Lafarga, A. et al. (11994). Distribución y caracterización fenotípica de Yersinia en muestras de origen humano y ambiental. Microbiologia 10, 83-92.
3. Sánchez-Céspedes, J., Navia, M. M., Martínez, R. et al. (2003). Clonal dissemination of Yersinia enterocolitica strains with various susceptibilities to nalidixic acid. Journal of Clinical Microbiology 41, 1769-71.
4. Ruiz, J. (2003). Mechanism of resistance to quinolones: target alterations, decreased accumulation and DNA gyrase protection. Journal of Antimicrobial Chemotherapy 51, 1109-17.
5. Saenz, Y., Ruiz, J., Zarazaga, M. et al. (2004). Effect of the efflux pump inhibitor Phe-Arg-β-naphthylamide on the MIC values of the quinolones, tetracycline and chloramphenicol, in Escherichia coli isolates of different origin. Journal of Antimicrobial Chemotherapy 53, 544-5.
6. Vila, J., Ruiz, J. & Navia, M. M. (1999). Molecular basis of quinolone resistance acquisition in Gram-negative bacteria. In Recent Research Developments in Antimicrobial Agents and Chemotherapy, 3rd edn (Pandalai, S. G., Ed.), pp. 323-44. Trivandrum, India.
7. Martínez-Martínez, L., Pascual, A. & Jacoby, G. A. (1998). Quinolone resistance from a transferable plasmid. Lancet 351, 797-9.
8. Ince, D. & Hooper, D. C. (2003). Quinolone resistance due to reduced target enzyme expression. Journal of Bacteriology 23, 6883-92.
9. National Committee for Clinical Laboratory Standards. (2003). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically - Sixth Edition: Approved Standard M7-A6. NCCLS, Villanova, PA, USA.
10. Ribera, A., Ruiz, J., Jimenez de Anta, M. T. et al. (2002). Effect of an efflux pump inhibitor on the MIC of nalidixic acid for Acinetobacter baumanii and Stenotrophomonas maltophilia clinical isolates. Journal of Antimicrobial Chemotherapy 49, 697-8.